Shanghai Haohai Biological Technology Co., Ltd. 6826.HK
6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2256.HK
Abbisko Cayman Limited 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 1672.HK
Ascletis Pharma Inc. 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 0690.HK
Uni-Bio Science Group Limited 9966.HK
Alphamab Oncology
Shanghai Haohai Biological Technology Co., Ltd. 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2256.HK
Abbisko Cayman Limited 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 1672.HK
Ascletis Pharma Inc. 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 0690.HK
Uni-Bio Science Group Limited 9966.HK
Alphamab Oncology
Performance
| Periode | 6826.HK | 2142.HK | 2171.HK | 2616.HK | 2256.HK | 2315.HK | 1672.HK | 0775.HK | 0690.HK | 9966.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 11.62 % | 78.13 % | 26.61 % | 174.50 % | 124.71 % | 92.88 % | 84.01 % | 17.11 % | 88.24 % | 117.04 % |
| YTD | 5.08 % | 545.96 % | 71.96 % | 181.22 % | 248.53 % | 174.22 % | 180.56 % | 117.07 % | 103.17 % | 319.53 % |
| 1Y | -20.06 % | 907.09 % | 302.24 % | 282.78 % | 296.13 % | 203.87 % | 573.33 % | 85.42 % | 96.92 % | 274.74 % |
| 3Y | 59.55 % | 833.58 % | 20.91 % | 83.24 % | 426.37 % | -15.70 % | 280.33 % | 43.55 % | 60.00 % | 141.85 % |
| 5Y | -16.59 % | 16.06 % | -46.23 % | -43.52 % | 23.95 % | -12.46 % | 204.01 % | 0.00 % | -2.29 % | -6.44 % |
| 10Y | -15.94 % | 16.06 % | -46.23 % | -46.42 % | 23.95 % | -12.46 % | -35.07 % | 20.27 % | -36.00 % | 6.59 % |
| From the beginning | -35.51 % | 16.06 % | -46.23 % | -46.42 % | 23.95 % | -12.46 % | -35.07 % | -69.39 % | -91.22 % | 6.59 % |